DEVELOPMENT AND VALIDATION OF A NOVEL EPS-METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER

Authors :: Matteo Bellone
Alberto Briganti
Luigi Nocera
Ettore Mosca
Vito Cucchiara
Annapaola Andolfo
Francesco Montorsi
Denise Drago
Alessandro Orro
Source :: The Journal of urology 201 (2019): E220–E220., info:cnr-pdr/source/autori:Andolfo, Annapaola; Drago, Denise; Cucchiara, Vito; Nocera, Luigi; Mosca, Ettore; Orro, Alessandro; Bellone, Matteo; Montorsi, Francesco; Briganti, Alberto/titolo:DEVELOPMENT AND VALIDATION OF A NOVEL EPS-METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER./doi:/rivista:The Journal of urology/anno:2019/pagina_da:E220/pagina_a:E220/intervallo_pagine:E220–E220/volume:201
Publication Year :: 2019
Publisher :: Williams and Wilkins Co., Baltimore, Md. , Stati Uniti d'America, 2019.
Abstract: INTRODUCTION AND OBJECTIVES:The lack of non-invasive diagnostic tests capable to distinguish between indolent and aggressive prostate cancer (PCa) may lead to over-diagnosis and overtreatment. Alth...

Subjects :: Oncology
medicine.medical_specialty
business.industry
Urology
Diagnostic test
medicine.disease
prostate cancer
expressed prostatic secretion
metabolomics
Prostate cancer
Metabolomics
Internal medicine
Medicine
business

Language :: English
Database :: OpenAIRE
Journal :: The Journal of urology 201 (2019): E220–E220., info:cnr-pdr/source/autori:Andolfo, Annapaola; Drago, Denise; Cucchiara, Vito; Nocera, Luigi; Mosca, Ettore; Orro, Alessandro; Bellone, Matteo; Montorsi, Francesco; Briganti, Alberto/titolo:DEVELOPMENT AND VALIDATION OF A NOVEL EPS-METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER./doi:/rivista:The Journal of urology/anno:2019/pagina_da:E220/pagina_a:E220/intervallo_pagine:E220–E220/volume:201
Accession number :: edsair.doi.dedup.....4fd99efcf876a8a028e422f99ef9dd2f

Tools